SIRT5 promotes chemoresistance through metabolic rewiring for nucleotide replenishing in refractory triple negative breast cancer
Published in American Association for Cancer Research, 2025
Ren, Z., Kurmi, K., Bernasocchi, T., Zaniewski, E., Joshi, S., Lam, G., Guo, C., Smidt, I., Dave, P., Maccio, A., & Kreuzer, J. (2025). SIRT5 promotes chemoresistance through metabolic rewiring for nucleotide replenishing in refractory triple-negative breast cancer. Cancer Research, 85(8_Supplement_1), 4449–4449. https://doi.org/10.1158/1538-7445.AM2025-4449